New article about EMA guidelines on FIH studies

Please see section SERVICES to read the whole text of the article, which was written based on new EMA guidelines on on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products.

Go back

News

Phase IIa diabetes study termination

We have succesfully completed phase II study for patients suffered from diabetes type II.

Read more …

Rivaroxaban bioequivalence studies

Our site has completed 5 bioequivalence studies with Rivaroxaban. The studies were conducted in our 1st phase unit in Kajetany.

Read more …

Clinical study with cladribine completed

We have succesfully completed phase I study for female patients suffering from multiple sclerosis.

Read more …

31st Great Final of WOŚP

31st Great Final of Wielka Orkiestra Świątecznej Pomocy.

Lets play till the end of the world and one day longer!

Read more …

Merry Christmas

We wish you Merry Christmas and Happy New Year!

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2024 © Bio Research Group. All rights reserved.

 

scroll to top ▲